LivaNova (LIVN) Consolidated Net Income (2014 - 2026)
LivaNova (LIVN) posted Consolidated Net Income of $23.1 million for Q1 2026, down 25.14% sequentially from $30.9 million in Q4 2025, and up 107.07% YoY from $11.2 million in Q1 2025.
LivaNova (LIVN) Consolidated Net Income (2014 - 2026) Analysis & Trends
LivaNova has reported Consolidated Net Income for 12 years, with the latest figure at $23.1 million in Q1 2026.
- Quarterly Consolidated Net Income rose 107.07% year-over-year to $23.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108.0 million (up 148.63% YoY) and the FY2025 annual result came in at -$242.4 million, down 483.26% from the prior year.
- Consolidated Net Income retreated to $23.1 million in Q1 2026 per LIVN's latest filing, from $30.9 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $55.9 million in Q4 2024 and troughed at -$327.3 million in Q1 2025.
- A 5-year average of -$13.2 million and a median of $16.4 million in 2023 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income jumped 1283.09% in 2024, then slumped 680.83% in 2025.
- Over 5 years, Consolidated Net Income stood at $1.7 million in 2022, then jumped by 867.81% to $16.4 million in 2023, then jumped by 241.72% to $55.9 million in 2024, then sank by 44.69% to $30.9 million in 2025, then decreased by 25.14% to $23.1 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered $23.1 million, $30.9 million, and $26.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 201.00 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 108.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.68 Mn |
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2020 | -498,000.00 |
| Mar 31, 2020 | -995,000.00 |